Clinical strategies aimed at mitigating or partially reversing biological aging markers at the cellular and systemic levels. These modalities focus on restoring youthful physiological parameters rather than merely treating age-associated pathology. They are often assessed through epigenetic clocks or functional biomarker analysis. The objective is to enhance healthspan by optimizing cellular performance.
Origin
This concept originates from the biogerontology research sphere, specifically targeting hallmarks of aging identified in cellular senescence and telomere dynamics. The “reversal” aspect is derived from observing phenotypic improvements correlating with younger biological ages in controlled studies. Modalities encompass lifestyle changes, targeted nutrient administration, and specific pharmacological agents influencing cellular repair.
Mechanism
Primary mechanisms often involve enhancing sirtuin activity or promoting mitophagy within metabolically active tissues. Some modalities work by reducing the burden of senescent cells through senolytics, thereby decreasing chronic inflammation. Furthermore, optimization of growth hormone and IGF-1 axes plays a role in tissue regeneration signaling. These actions collectively aim to improve tissue plasticity and reduce molecular damage accumulation.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.